Current Weather
The Spy FM

Failure Of Lilly Drug Is Latest Alzheimer’s Setback

Filed by KOSU News in Business.
August 24, 2012

An experimental drug that aimed to slow the development of plaques and help clear them from the brains of Alzheimer’s patients failed in two late-stage studies conducted by Eli Lilly & Co., the company said.

It’s another setback in a field marked by failure. Earlier this month, Pfizer and Johnson & Johnson said they were dropping development of a similar experimental drug after big clinical studies showed it wasn’t working. And a year ago, Lilly announced another Alzheimer’s drug flunked late-stage clinical tests.

The latest disappointment involved Lilly’s solanezumab, a drug given by IV every four weeks. The studies, involving more than 2,000 patients with mild-to-moderate Alzheimer’s disease, lasted a year and a half.

Patients who got the drug instead of a placebo were no better off on tests of memory and thinking. The same was true about tests on tasks of daily life.

After combining the results from both trials, Lilly said it found some reason to think there might be an effect from treatment for some patients.

“We recognize that the solanezumab studies did not meet their primary endpoints, but we are encouraged by the pooled data that appear to show a slowing of cognitive decline,” said a statement from John C. Lechleiter, Ph.D., Lilly’s chairman and CEO.

While acknowledging the disappointing outcome, the Alzheimer’s Association said in a statement that the pooled data contained “new and encouraging information.”

But the pooling of data by Lilly also drew skeptical responses. Sally Church, a drug industry consultant, tweeted, that it’s “truly despair” when drugmakers “raise unnecessary hope/hype for [patients] when they have a clearly failed trial.”

Pieter Droppert, a colleague of Church’s, rounded up some of the on-the-fly analysis, including comments from John LaMattina, formerly head of research at Pfizer, and Derek Lowe, a drug industry science and blogger. The upshot was negative.

Lilly plans to talk with regulators about what to do next. More details on the results, which were sparse today, will be presented at medical meetings in October. [Copyright 2012 National Public Radio]

Leave a Reply

7PM to 9PM Juke Joint Revival

Juke Joint Revival

Juke Joint Revival rivals any Rockabilly/Roots show on the air today, and the host of that program, Jenni Zee, lives and breathes the Rockabilly lifestyle. Her show has drawn the attention of Rockabilly fans the world over.

Listen Live Now!

9PM to 10PM The Spy

The Spy

An eclectic mix of the Spy's library of more than 10,000 songs curated by Ferris O'Brien.

View the program guide!

10PM to 11PM The Blank Generation

The Blank Generation

Our punk show, The Blank Generation, is hosted by Katie Jones and Chad Hunnicutt. Katie has been attending punks shows for more than half her life. Chad is a member of local band, The Muck Savages.

View the program guide!

Upcoming Events in your area (Submit your event today!)

Streaming audio and podcasts

Stream KOSU on your smartphone

Phone Streaming

SmartPhone listening options on this page are intended for many iPhones, Blackberries, etc. with low-cost software applications available to listen to our full-time web streams, both News on KOSU-1 and Classical on KOSU-2.

Learn more about our complete range of streaming services

We're perfecting the patient experience - Stillwater Medical Center